NAVIDEA BIOPHARMACEUTICALS, INC. (24) | Stock Agreements (11)

Recent Contracts

Section 382 Rights Agreement, dated as of April 7, 2022, between Navidea Biopharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC, as Rights Agent (Filed With SEC on April 12, 2022)
Amendment to Stock Purchase Agreement and Letter of Investment Intent by and between the Company and Investor dated July 8, 2021 (Filed With SEC on July 13, 2021)
Stock Purchase Agreement and Letter of Investment Intent by and between the Company and Investor dated March 2, 2021 (Filed With SEC on March 4, 2021)
Stock Purchase Agreement and Letter of Investment Intent, by and between the Company and Keystone (Filed With SEC on September 2, 2020)
Form of Common Stock Purchase Agreement (Filed With SEC on September 2, 2020)
Stock Purchase Agreement, effective August 9, 2020, by and between Navidea Biopharmaceuticals, Inc. and Jubilant Radiopharma (Filed With SEC on August 12, 2020)
Stock Purchase Agreement and Letter of Investment Intent by and between the Company and the Investor (Filed With SEC on May 12, 2020)
Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and Keystone Capital Partners, LLC (Filed With SEC on March 18, 2020)
Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and John K. Scott (Filed With SEC on March 18, 2020)
Stock Purchase Agreement, dated December 6, 2019, among Navidea Biopharmaceuticals, Inc. and the purchasers named therein (Filed With SEC on December 11, 2019)
Stock Purchase Agreement, dated March 22, 2019, between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr (Filed With SEC on May 9, 2019)